SCHEMBL31232499

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	13/20	0.68

▸	NPBWR1	P48145	3/20	0.61

▸	ECE1	P42892	1/20	0.60

▸	MUS81	Q96NY9	1/20	0.60

▸	KISS1R	Q969F8	3/20	0.60

▸	PCSK9	Q8NBP7	1/20	0.59

▸	CCKBR	P32239	1/20	0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29351278	0.96	GLP1R (0.69)	GLP1RNPBWR1KISS1RCCKBR
SCHEMBL30906511	0.96	GLP1R (0.71)	GLP1RECE1MUS81KISS1RCCKBR
SCHEMBL30906532	0.96	GLP1R (0.71)	GLP1RECE1MUS81KISS1RCCKBR
SCHEMBL30906503	0.95	GLP1R (0.72)	GLP1RNPBWR1ECE1MUS81CCKBR
SCHEMBL31000949	0.94	GLP1R (0.75)	GLP1RECE1MUS81CCKBR
SCHEMBL30906493	0.94	GLP1R (0.70)	GLP1RNPBWR1ECE1MUS81CCKBR
SCHEMBL30906555	0.94	GLP1R (0.68)	GLP1RECE1MUS81KISS1RCCKBR
SCHEMBL30906536	0.93	GLP1R (0.71)	GLP1RNPBWR1ECE1MUS81
SCHEMBL30906486	0.93	GLP1R (0.70)	GLP1RNPBWR1ECE1MUS81CCKBR
SCHEMBL30906510	0.93	GLP1R (0.67)	GLP1RECE1MUS81KISS1RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4642492-A1	AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES	Hangzhou Seehe Biotechnology Co., Ltd (CN)	2025-11-05	—	—	EP	claimed
WO-2024240173-A1	AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES	HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN)	2024-11-28	—	—	WO	claimed